BGNE News and Press, BeiGene Ltd.

2025-04-23 16:05:00 ET Shares of lung cancer biotech Summit Therapeutics (NASDAQ: SMMT) rocketed 14.7% on Wednesday as of 1:45 p.m. ET. The markets were broadly up today on a potential easing of trade tensions with China. That should be a positive for Summit, as its main partner...

Positive opinion for first-line treatment of extensive-stage small cell lung cancer based on results of RATIONALE-312 study demonstrating statistically significant overall survival benefit for TEVIMBRA in combination with chemotherapy BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE:...